Differential phagocytosis induces diverse macrophage activation states in malignant gliomas

This study highlights that macrophage fate is intimately linked to the molecular properties of what they phagocytose. Phagocytosis is not a singular, uniform process but a dynamic and context-dependent event that drives macrophage specialization and plasticity. By demonstrating that RT and anti-CD47 therapy shape distinct macrophage phenotypes through their effects on tumor immunogenicity, this study provides a framework for understanding how to harness and reprogram macrophage activity for therapeutic benefit. These findings underscore the potential of targeting macrophage plasticity as a strategy to enhance antitumor immunity and improve outcomes in malignant gliomas and other diseases.

Authors

Institutions

Publication Details

Journal
Journal for ImmunoTherapy of Cancer
Published
2025-09-01
DOI
https://doi.org/10.1136/jitc-2025-012211
Citations
2
Primary Topic
Phagocytosis and Immune Regulation
Type
article
Field-Weighted Citation Impact
1.59

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Differential phagocytosis induces diverse macrophage activation states in malignant gliomas

Kent Riemondy, Rajeev Vibhakar, Bridget Sanford, Nicholas K. Foreman et al.
2 citations
Journal for ImmunoTherapy of Cancer
Phagocytosis and Immune Regulation
1.59
article

Differential phagocytosis induces diverse macrophage activation states in malignant gliomas

Kent Riemondy, Rajeev Vibhakar, Bridget Sanford, Nicholas K. Foreman, Senthilnath Lakshmanachetty, Ilango Balakrishnan, Sujatha Venkataraman, Siddhartha S. Mitra, Nathan Dahl, Eric Prince, Andrew M. Donson, Todd C. Hankinson, Vincent Chen
article en
2 citations

Abstract

This study highlights that macrophage fate is intimately linked to the molecular properties of what they phagocytose. Phagocytosis is not a singular, uniform process but a dynamic and context-dependent event that drives macrophage specialization and plasticity. By demonstrating that RT and anti-CD47 therapy shape distinct macrophage phenotypes through their effects on tumor immunogenicity, this study provides a framework for understanding how to harness and reprogram macrophage activity for therapeutic benefit. These findings underscore the potential of targeting macrophage plasticity as a strategy to enhance antitumor immunity and improve outcomes in malignant gliomas and other diseases.

Journal for ImmunoTherapy of CancerVol. 13(9)
University of California, San Francisco (US), Morgan Adams Foundation (US), Center for Cancer and Blood Disorders (US), Neurological Surgery (US), University of Colorado Anschutz Medical Campus (US)
Alex's Lemonade Stand Foundation for Childhood Cancer, American Brain Tumor Association, Cancer League of Colorado, Morgan Adams Foundation, National Cancer Institute
Openalex Percentile: Top 15%
Phagocytosis and Immune Regulation
1.59
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.